NCPCR bars all states from selling Johnson & Johnson baby shampoo

By Nikita Chaurasia  Date: 2019-04-29

NCPCR bars all states from selling Johnson & Johnson baby shampoo

NCPCR has conducted a sample test of the company’s baby talcum powder and shampoo products from authorities of five zones in the country

Reports confirm that the National Commission for Protection of Child Rights or NCPCR has asked all the states in India to stop the sale of Johnson & Johnson’s baby shampoo product, after getting laboratory test results from Rajasthan that said the product consists the harmful chemical formaldehyde.

Apparently, the apex child rights body has sent a letter to chief secretaries of all states stating a ban on the sale of the Johnson & Johnson’s baby shampoo and also to remove it from the inventory of shops. The Drug Testing Laboratory in Jaipur has confirmed the presence of formaldehyde after its test results.

Sources familiar with the matter informed that the NCPCR has conducted a sample test of the company’s baby talcum powder and shampoo products from authorities of five zones in the country- Jharkhand in the east, Assam in north east, Madhya Pradesh in central India, Andhra Pradesh in the south, and Rajasthan in the west. Orders for the test were given after reports suggested the presence of carcinogenic substance and asbestos in the products.

Sources further added that the order to bar sale of Johnson & Johnson baby shampoo was issued based on the test reports of the samples of the product which came in from Rajasthan. Samples from rest of the four states are still undergoing laboratory tests. The NCPCR has also asked Rajasthan to provide the test reports for talcum powder samples as early as possible.

Supposedly, back in December, Central Drugs Standard Control Organization (CDSCO), an Indian drug regulator had given an order to Johnson and Johnson to stop producing its baby powder product using raw materials in two Indian factories until lab test results show that they are free from asbestos.

Last year, reports had claimed that the US-based company had already known for years that its baby powder product contained asbestos.

Source Credit: https://www.businesstoday.in/current/corporate/ncpcr-asks-states-to-bar-sale-of-johnson-and-johnson-baby-shampoo/story/341063.html

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

France might ban short domestic flights to reduce its carbon footprint

France might ban short domestic flights to reduce its carbon footprint

By Nikita Chaurasia

French lawmakers recently came to a unanimous decision to ban domestic flights for distances that can be covered by train in over two-and-a-half- hours. The country aims to impose these restrictions in an effort to reduce carbon emissions, even as th...

Kavak secures USD 485 million in funding, eyes Latin America expansion

Kavak secures USD 485 million in funding, eyes Latin America expansion

By Nikita Chaurasia

Kavak, a Mexico-based used-car platform, has reportedly reached a valuation of USD 4 billion after securing USD 485 million during a new funding round. This makes it the fastest-growing as well as the most valued company in Latin America. The latest...

Zydus seeks DCGI approval for PegIFN drug to treat COVID-19 patients

Zydus seeks DCGI approval for PegIFN drug to treat COVID-19 patients

By Nikita Chaurasia

Indian pharmaceutical company Zydus Cadila is reportedly seeking approval from DCGI (Drug Controller General of India) for its PegIFN (Pegylated Interferon Alpha-2b), a hepatitis C drug, to treat COVID-19 patients, after its third phase of clinical t...

LinkedIn confirms launch of a social audio platform to rival Clubhouse

LinkedIn confirms launch of a social audio platform to rival Clubhouse

By Nikita Chaurasia

LinkedIn, the popular employment-oriented online service, has confirmed that it is testing a social audio experience in its app which could offer users with better connectivity in their networks. Although several social media giants such as Twitter ...

Pfizer begins Phase-1 trials of oral COVID-19 antiviral drug in U.S.

Pfizer begins Phase-1 trials of oral COVID-19 antiviral drug in U.S.

By Nikita Chaurasia

Pfizer Inc., an American multinational pharmaceutical corporation, has recently announced to have started the early phase trials for its oral antiviral drug for Coronavirus. The company revealed that first phase trials of the experimental drug, PF-07...